Novel medicine for treating malaria controlling malaria spreading

Abstract

The medicine for treating malaria and controlling malaria spreading consists of artemisinin or its derivative, or the mixture of artemisinin or its derivative and antimalarial agent with long or medium half life, or separated packed artemisinin or its derivative and antimalarial agent with long or medium half life, in 1-500 weight portions; and lower dosage of primaqine or its salt in 0.1-1 weight portions. Clinical experiment shows that the medicine has the features of high and fast curative effect, low toxicity, short treating period, convenient taking and fast killing gametophyte to block the spreading of malaria.

Description

Technical field

[0001] The invention relates to medicine, especially a new medicine for treating and blocking malaria transmission and controlling malaria epidemic. Background technique

[0002] The medicines for treating malaria in the prior art are ineffective against the middle and late gametocytes of Plasmodium; while the conventional dose of primaquine phosphate can kill the gametocytes, but its side effects are large, and it is easy to cause hemolysis in patients, especially for those lacking G-6-PD patient. The use of artemisinin or derivatives and ultra-low doses of primaquine to treat and block the spread of malaria has not been reported yet. Contents of the invention

[0003] The purpose of the present invention is to overcome the deficiencies of the prior art and provide a new drug that can quickly and powerfully kill gametocytes at each stage, prevent hemolysis after taking it, block malaria transmission and control malaria epidemic.

[0004] The purpose of t...